Advertisement

Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat

  • Tomoko Ito
  • Mami Saito
  • Tomohiro Uchino
  • Mamoru Senna
  • Michele Iafisco
  • Maria Prat
  • Lia Rimondini
  • Makoto Otsuka
Article

Abstract

Highly soluble amorphous calcium phosphate powder (ACP) was added to the alginate gel as a buffering agent, in an attempt to enable widely controlled release while avoiding an acidification of the gel-environment. Therapeutic effects of the ACP-containing alginate gel which slowly releases a drug, simvastatin, on osteoporosis model rats were examined. A model drug, simvastatin, incorporated in the alginate gel with ACP up to 0.5%, was continuously released for a long time under the acidic condition. The release rate was controlled by the amount of ACP, serving as a buffer to suppress acidity. When the alginate solution intramuscularly injected in the rat, a soft gel was formed in the injected site. Simvastatin released from the gel containing 0.5% of ACP showed high therapeutic effect on osteoporosis rat. Thus, the present injectable long-sustained release system is expected to be a novel drug delivery controlling device.

Keywords

Alginate Simvastatin Bone Mineral Content Simulated Body Fluid Sodium Alginate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was partly supported by the Japan Society for the Promotion of Science (nos. 21700494).

References

  1. 1.
    Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946–9.CrossRefGoogle Scholar
  2. 2.
    Du Z, Chen J, Yan F, Xiao Y. Effects of simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Implants Res. 2009;20:145–50.CrossRefGoogle Scholar
  3. 3.
    Du Z, Chen J, Yan F, Doan N, Ivanovski S, Xiao Y. Serum bone formation marker correlation with improved osseointegration in osteoporotic rats treated with simvastatin. Clin Oral Implants Res. 2011 (in press). doi: 10.1111/j.1600-0501.2011.02341.x.
  4. 4.
    Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000;36:2325–32.CrossRefGoogle Scholar
  5. 5.
    Uchida A, Shinto Y, Araki N, Ono K. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J Orthop Res. 1992;10:440–5.CrossRefGoogle Scholar
  6. 6.
    Langer R. Invited review polymeric delivery systems for controlled drug release. Chem Eng Commun. 1980;6:1–48.CrossRefGoogle Scholar
  7. 7.
    Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59:234–48.Google Scholar
  8. 8.
    Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21:2335–46.Google Scholar
  9. 9.
    Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery system. Nature. 1997;388:860–2.CrossRefGoogle Scholar
  10. 10.
    Lin CC, Metters AT. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev. 2006;58:1379–408.CrossRefGoogle Scholar
  11. 11.
    Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998;31:267–285.CrossRefGoogle Scholar
  12. 12.
    Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci. 2006;6:623–33.CrossRefGoogle Scholar
  13. 13.
    Elnashar MM, Yassin MA, Moneim AEFA, Bary EMA. Surprising performance of alginate beads for the release of low-molecular-weight drugs. J Appl Polym Sci. 2010;116:3021–6.Google Scholar
  14. 14.
    Donati I, Paoletti S. Material Properties of Alginates. In: Steinbüchel A, series editor, Rehm BHA, editor. Microbiology monographs 13; alginates: biology and applications. Berlin: Springer; 2009. pp. 1–53.Google Scholar
  15. 15.
    Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec. 1989;224:317–24.CrossRefGoogle Scholar
  16. 16.
    Eanes ED, Gillessen IH, Postner AS. Intermediate states in the precipitation of hydroxyapatite. Nature. 1965;208:365–7.CrossRefGoogle Scholar
  17. 17.
    Eanes ED, Postner AS. Kinetics and mechanism of conversion of noncrystalline calcium phosphate to crystalline hydroxyapatite. Trans NY Acad Sci II. 1965;28:233–41.Google Scholar
  18. 18.
    Zahid A. Calcium phosphates in biological and industrial systems. Boston: Kluwer academic publishers; 1998. p. 21–39.Google Scholar
  19. 19.
    Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res. 1990;24:721–34.CrossRefGoogle Scholar
  20. 20.
    Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907–15.CrossRefGoogle Scholar
  21. 21.
    Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem. 1962;4:330–4.CrossRefGoogle Scholar
  22. 22.
    Mill PJ. The nature of the interactions between flocculent cells in the flocculation of Saccharomyces cerevisiae. J Gen Microbiol. 1964;35:61–8.Google Scholar
  23. 23.
    Kim SJ, Lee CK, Lee YM, In Young Kim, Sun I. Kim. Electrical/pH-sensitive swelling behavior of polyelectrolyte hydrogels prepared with hyaluronic acid–poly(vinyl alcohol) interpenetrating polymer networks. React Funct Polym. 2003;55:291–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Tomoko Ito
    • 1
  • Mami Saito
    • 2
  • Tomohiro Uchino
    • 1
    • 3
  • Mamoru Senna
    • 1
    • 4
  • Michele Iafisco
    • 5
    • 6
  • Maria Prat
    • 5
  • Lia Rimondini
    • 5
  • Makoto Otsuka
    • 1
    • 2
  1. 1.Research Institute of Pharmaceutical Sciences, Musashino UniversityTokyoJapan
  2. 2.Faculty of Pharmaceutical Sciences, Musashino UniversityTokyoJapan
  3. 3.College of Engineering, Nihon UniversityFukushimaJapan
  4. 4.RIKEN Innovation CenterSaitamaJapan
  5. 5.Dipartimento di Scienze Mediche, Università del Piemonte OrientaleNovaraItaly
  6. 6.Dipartimento di Chimica “G. Ciamician”, Alma Mater Studiorum, Università di BolognaBolognaItaly

Personalised recommendations